Antiplatelet therapy and outcomes after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis

ALA Garton, K Berger, AE Merkler, H Kamel… - Clinical Neurology and …, 2023 - Elsevier
Background The efficacy of antiplatelet therapy (APT) after aneurysmal subarachnoid
hemorrhage (aSAH) remains unclear. We performed a systematic review and meta-analysis …

Antiplatelet therapy and outcomes after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.

ALA Garton, K Berger, AE Merkler, H Kamel… - Clinical Neurology …, 2023 - europepmc.org
Background The efficacy of antiplatelet therapy (APT) after aneurysmal subarachnoid
hemorrhage (aSAH) remains unclear. We performed a systematic review and meta-analysis …

Antiplatelet therapy and outcomes after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis

ALA Garton, K Berger, AE Merkler… - Clinical neurology … - pubmed.ncbi.nlm.nih.gov
Background The efficacy of antiplatelet therapy (APT) after aneurysmal subarachnoid
hemorrhage (aSAH) remains unclear. We performed a systematic review and meta-analysis …